End Cash: The amount of cash held by the company for the given period.
Zhengye Biotechnology Holding Limited (ZYBT) had End Cash of $7.20M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$16.64M |
|
$-9.98M |
|
$13.23M |
|
$3.41M |
|
$26.72M |
|
$-10.08M |
|
$-0.20M |
|
$-10.28M |
|
$-10.30M |
|
$-11.87M |
|
$-11.87M |
|
$-11.87M |
|
$-11.88M |
|
$-10.08M |
|
$-6.37M |
|
47.35M |
|
47.35M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$19.65M |
|
$33.86M |
|
$42.76M |
|
$62.41M |
|
$17.23M |
|
$1.27M |
|
$1.33M |
|
$18.56M |
|
$43.85M |
|
$36.02M |
|
$43.85M |
|
47.39M |
|
| Cash Flow Statement Financials | |
$1.91M |
|
$-1.81M |
|
$4.62M |
|
$2.66M |
|
|
End Cash |
$7.20M |
$4.54M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.14 |
|
-- |
|
-- |
|
0.03 |
|
0.24 |
|
20.51% |
|
-60.60% |
|
-60.60% |
|
-38.30% |
|
-61.78% |
|
-59.99% |
|
$1.77M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
2.36 |
|
5.62 |
|
64.91 |
|
-27.06% |
|
-32.94% |
|
-19.01% |
|
-26.30% |
|
$0.93 |
|
$0.04 |
|
$0.04 |
|